New synthetic nanoparticle could disinfect, depollute, and desalinate contaminated water and then get removed magnetically
Among its many talents, silver is an antibiotic. Titanium dioxide is known to glom on to certain heavy metals and pollutants. Other materials do the same for salt. In recent years, environmental engineers have sought to disinfect, depollute, and desalinate contaminated water using nanoscale particles of these active materials. Engineers call them nanoscavengers. The hitch from a technical standpoint is that it is nearly impossible to reclaim the nanoscavengers once in the water.
In a paper published online May 14 in the journal Nature Communications, an interdisciplinary team of engineers at Stanford University announces it has developed a new type of nanoscavenger with a synthetic core that is ultraresponsive to magnetism, allowing the easy and efficient recovery of virtually every one of the nanoscale purifiers.
“In contaminated water, nanoscavengers float around, randomly bumping into and killing bacteria or attaching themselves to the molecular pollutants they are after,” said Shan Wang, the study’s senior author and a professor of material science and engineering and jointly of electrical engineering. “When the contaminants are either stuck to the nanoscavenger or dead, the magnet is turned on and the particles vanish.”
ULTRARESPONSIVE TO MAGNETISM
The use of magnetism to recover nanoscavengers is not new. There are commercial technologies today that have fashioned nanoscavengers with a core of magnetic iron oxide surrounded by an active material, but these ingenious methods are less than perfect. Iron oxide is not absolutely responsive to magnetism and too many nanoscavengers remain in the water for it to be considered safe for human use.
The Stanford advance replaces the iron oxide with a synthetic material. The Stanford core is, in reality, not a single material, but a disk of several layers – magnetic outer layers of the synthetic material sandwiched on either side of a titanium center, but with a twist.
“The magnetic moments of the two outer layers are opposed. The direction of the magnetic force in the top layer and the bottom layer point in opposite directions, effectively canceling the magnetic properties of the material,” said Mingliang Zhang, a doctoral candidate in material science and engineering and co-first author of the study.
In their natural state, the new nanoscavengers are not magnetic and would not be attracted to another magnetic material. When the composite discs are exposed to a strong magnetic field, however, the magnetism of the two opposing fields turn into alignment, not just becoming magnetic but compounding the magnetic effect.
In doing so, the nanoscavengers become ultraresponsive to magnetism, far more so than the base iron oxide used in today’s technologies. The Stanford team has dubbed its advance with the oxymoronic name: “synthetic antiferromagnetic cores.” The prefix anti- in this case means in opposite direction, not non-magnetic.
With a successful core created, the researchers then cap it with silver or titanium dioxide or another reactive material depending upon the contaminant they are targeting. In live tests using synthetic-core, silver-capped nanoscavengers immersed in water tainted with E. coli bacteria, using a silver dosage of just 17 parts per million, the Stanford team was able to kill 99.9% of the bacteria in just 20 minutes. Better yet, they removed virtually all of the nanoscavengers in just five minutes of exposure to a permanent magnet.
The Latest Bing News on:
- Feed has no items.
The Latest Google Headlines on:
The Latest Bing News on:
- KAUST researchers develop a safe, fast and cheap testing method to detect viruseson February 25, 2021 at 6:23 pm
A safe, fast and cheap testing method that uses magnetic nanoparticles to detect viruses in both clinical and wastewater samples has been developed by KAUST researchers.
- Is Celsion Stock a Buy Right Now? This Is What You Need to Knowon February 25, 2021 at 4:26 pm
Despite the recent market-wide pullback, oncology drug-maker Celsion (CLSN) is enjoying a breakout year, with shares up by 210% year-to-date. One Street analyst thinks the stock has a way to run yet.
- Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in ...on February 25, 2021 at 5:54 am
Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today provided an update on its Phase I/II OVATION 2 Study ...
- Clene Nanomedicine Presents Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021on February 25, 2021 at 4:35 am
Blinded interim data from VISIONARY-MS continue to support the potential of CNM-Au8 to drive meaningful neurological functional improvements in MS patientsInterim REPAIR-MS results provide further ...
- Biomaterials Market Latest Research On Industry Growth, Trends, Top Players, & Key Regions By 2027on February 24, 2021 at 7:03 pm
The scope of the report includes a detailed study of global and regional markets on Biomaterials Market with the ...
- Oncorus Inc.: Undervalued Cancer Viral Immunotherapy Opportunityon February 23, 2021 at 7:01 am
Phase 1 monotherapy data for ONCR-177 in cancers like breast, melanoma and head and neck cancer is expected in the second half this year. I do much more than just articles at Vasuda Healthcare ...
- Celsion Surges as FDA Fast-Tracks Ovarian-Cancer Drugon February 22, 2021 at 12:17 pm
Celsion shares jumped after the drugmaker received FDA Fast Track status for its Phase 2 treatment for advanced ovarian cancer.
- CLSN Stock Price Increases Over 50% Pre-Market: Why It Happenedon February 22, 2021 at 6:10 am
The stock price of Celsion Corporation (NASDAQ: CLSN) is trading at over 50% pre-market. This is why it happened.
- Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Canceron February 22, 2021 at 4:32 am
Celsion’s Commitment to Promoting Immune System Solutions to Fight Life-Threatening Diseases Granted an Accelerated Development Pathway Designation Provides Potential for an Expedited Regulatory ...
- Scarcity of niche biotech ingredients hinder vaccine productionon February 18, 2021 at 8:39 pm
Scaling up production of formerly niche substances such as lipid nanoparticles for a global vaccine drive has been among the most complex challenges behind the effort.